Document Detail


First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.
MedLine Citation:
PMID:  22580248     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Aims: To report our first-in-man experience with a new cerebral embolic deflection device (SMT Embolic Deflection Device) during transcatheter aortic valve implantation (TAVI). A significant number of strokes and brain infarcts are caused by embolisation of atherosclerotic material, clots and other debris during various phases of invasive cardiac procedures, especially TAVI. The application of a temporary filter in the aortic arch averting dislodged emboli from entering the cerebral circulation might prevent this. Methods and results: In 15 patients (mean age 79 years) with severe aortic stenosis undergoing percutaneous transfemoral or transapical aortic valve implantation, the SMT Embolic Deflection Device was advanced utilising the contralateral femoral artery access using a 9 Fr delivery sheath. Once deployed in the aortic arch, a porous membrane shields the supraaortic-cerebral trunks by deflecting emboli away from the cerebral circulation. Embolic material is not contained or removed by the device. A 6 Fr pigtail catheter can be used through the same sheath throughout the whole procedure. Brain diffusion weighted (DW)-MRI was obtained in 10 patients before and at 4 days after (±2 days) the procedure and retrospectively compared to 20 patients previously undergoing TAVI without a protection device. Successful placement of the embolic protection device was achieved in all patients. Additional procedural time due to the use of the device was 7 min (±2 min). There were no procedural complications. No patient developed new neurological symptoms or clinical findings of stroke except one patient who suffered from a transient ischaemic attack (TIA) two days after the procedure. DW-MRI showed 3.2 new cerebral lesions per patient, compared to 7.2 new lesions per patient in the group without SMT filter. Conclusions: In this first-in-man experience, the feasibility of a new embolic deflection device is demonstrated. Larger randomised, prospective studies are required to confirm these findings and prove safety and efficacy by reducing the incidence of cerebral embolism and stroke after TAVI.
Authors:
Kevin Onsea; Pierfrancesco Agostoni; Mariam Samim; Michiel Voskuil; Jolanda Kluin; Ricardo Budde; Jeroen Hendrikse; Faiz Ramjankhan; Jan van Klarenbosch; Pieter Doesburg; Gertjan Sieswerda; Pieter Stella
Related Documents :
22494778 - Risk of recurrent stroke before carotid endarterectomy: the ansyscap study.
25000348 - Tetralogy of fallot: aorto-pulmonary collaterals and pulmonary arteries have distinctly...
21439768 - Comparison of clipping versus ligation of side-branches during saphenous vein graft har...
2783098 - Traumatic internal carotid artery aneurysm and massive epistaxis.
2401918 - Modalities of origin of the middle cerebral artery. incidence on the arrangement of the...
12027198 - Monocyte chemoattractant protein-1 expression in intimal hyperplasia of vein grafts in ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  8     ISSN:  1969-6213     ISO Abbreviation:  EuroIntervention     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-05-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  France    
Other Details:
Languages:  eng     Pagination:  51-6     Citation Subset:  IM    
Affiliation:
Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Implementation of primary angioplasty in Europe: Stent for Life initiative progress report.
Next Document:  First experience with endovascular ultrasound renal denervation for the treatment of resistant hyper...